Pfizer Inc (PFE)

$25.33 -0.42 (-1.63%)
Market Cap 146.76B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.48
Forward PE 8.69
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 37,110,000
Avg Vol 38,161,227
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 6%
Beta 0.35
Analysts Sell
Price Target $29.24

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
UsingAGodAlgorithm
UsingAGodAlgorithm May. 16 at 10:53 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile. We also covered these names . $DE $ARM $PFE $NVO
0 · Reply
Mike22332233
Mike22332233 May. 16 at 10:51 PM
$SLS Some think $40 Bil BO is silly ... really, FOR AN EFFECTIVE CURE FOR CANCER !!! ... and then across 20 other cancers with WT1 !!! Add in the SLS001 platform!!! ... KEYTRUDA has sales of $34 Bil per year and does NOT cure anything ... We will see how silly it is when $MRK, $ABBV and $PFE are in a bidding war to buy out $SLS ... Single BEST asymmetrical investment idea in my over 40 years investing ... ALL my profits from every other Special Situation Stock I have found (see my other posts) have been plowed back into more SLS ... If you agree with what I will say, then LIKE this and FOLLOW me 👉 @Mike22332233 ...
3 · Reply
Mike22332233
Mike22332233 May. 16 at 9:29 PM
$SLS PART 2 of 2 .. Even with the BAT arm at 14.7 mOS which is almost twice as long as should be expected … EFFECTIVELY, those getting GPS that had an immune response (80% of them) ARE NOT PASSING AWAY!!! ... GAME CHANGING FOR CANCER !!! When the trial ends at the 80th event, I believe you would have ALL 63 in the BAT Control arm passed away, AND ONLY 17 OF THE 63 GPS PATIENTS PASSED AWAY … 46 of the 63 will be alive and living into their 4th yr and some into their 5th year…. This has EFFECTIVELY STOPPED CANCER FROM KILLING THEM IN THIS TYPE OF CANCER !! ... There are an additional 20 or so Cancers with the WT1 within them … as I said before, likely $ABBV or $MEK or $PFE doing a BUY OUT WITHIN 3 months of the readout, and my MAXIMUM PRICE OF $150 to $175 (a $30 to $35 Billion valuation) for the BO may very well be much too low if the HR is GAME-CHANGING at 0.27-0.35 ... if so, expect a bidding war and final BO at $222 !!! ... If you agree then LIKE this and FOLLOW me 👉 @Mike22332233
3 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 16 at 7:13 PM
$SLS it is inevitable - the 80th Event PR is coming, Phase 3 Registrational Results and FDA Green light worth $40B to big Pharma - are Coming. ANY - DAY - NOW GPS P3 Results - truly worth $40B + the Instant the REGAL Results are announced - GPS MOS 30-36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the $10B MCap Range / $50 Per Share - AND CLIMBING And to Bottom LINE 009 / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value. Gleevc - Imatinib, Imbrutinib - Imbruvica, Upadactinib - Rinvoq Upadactinib <- say that 3 x fast $PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor Novartis' Kisqali -Ribociclib CDKinase Inhibitor $LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor $SLS Tambiciclib CDKInase Inhibitor reddit.com/r/sellasLifescience ... for anyone interested in DD/ i been here -invested a long time/ if you have an interest in $
0 · Reply
morgangj
morgangj May. 16 at 4:00 PM
$PFE
0 · Reply
morgangj
morgangj May. 16 at 3:23 PM
$PFE
0 · Reply
morgangj
morgangj May. 16 at 3:18 PM
$PFE
0 · Reply
IdioSyncro
IdioSyncro May. 16 at 2:05 AM
$PFE
0 · Reply
pasuny
pasuny May. 16 at 12:44 AM
$PFE it's been 5 Pho King years...
1 · Reply
pasuny
pasuny May. 16 at 12:41 AM
$PFE 씨발 젖같네 도대체 왜 이러지? 씨발 좆도 5년동안 빌빌 거리네... 좆도 씨발 물려서 팔지도 못 하고... 진짜 개좆같네... 씨발 경영진...
0 · Reply
Latest News on PFE
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 2 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-14T17:29:38.000Z - 2 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:23:39.000Z - 3 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

Arvinas price target raised to $16 from $14 at BofA

2026-05-13T19:22:15.000Z - 3 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

Pfizer says EC grants marketing approval to expand indication for Hympavzi

2026-05-13T11:10:14.000Z - 3 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 3 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

2026-05-13T07:12:25.000Z - 3 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

2026-05-12T17:45:03.000Z - 4 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

2026-05-12T16:35:26.000Z - 4 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

2026-05-12T13:02:04.000Z - 4 days ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

ARVN RIGL

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 4 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 4 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-08T22:49:53.000Z - 8 days ago

Mixed options sentiment in Pfizer with shares down 1.52%

Mixed options sentiment in Pfizer with shares up 0.28%

2026-05-07T01:58:20.000Z - 9 days ago

Mixed options sentiment in Pfizer with shares up 0.28%

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

2026-05-05T20:09:06.000Z - 11 days ago

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 11 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 11 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 11 days ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 11 days ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 11 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 11 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 11 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 11 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 11 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 11 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 11 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 15 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 17 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 17 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 18 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 18 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 22 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 23 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 24 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 24 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 25 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 26 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 26 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 4 weeks ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 5 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 6 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 6 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 6 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 6 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 7 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 7 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 7 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 7 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 7 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 7 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 2 months ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 2 months ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 2 months ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 2 months ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

UsingAGodAlgorithm
UsingAGodAlgorithm May. 16 at 10:53 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile. We also covered these names . $DE $ARM $PFE $NVO
0 · Reply
Mike22332233
Mike22332233 May. 16 at 10:51 PM
$SLS Some think $40 Bil BO is silly ... really, FOR AN EFFECTIVE CURE FOR CANCER !!! ... and then across 20 other cancers with WT1 !!! Add in the SLS001 platform!!! ... KEYTRUDA has sales of $34 Bil per year and does NOT cure anything ... We will see how silly it is when $MRK, $ABBV and $PFE are in a bidding war to buy out $SLS ... Single BEST asymmetrical investment idea in my over 40 years investing ... ALL my profits from every other Special Situation Stock I have found (see my other posts) have been plowed back into more SLS ... If you agree with what I will say, then LIKE this and FOLLOW me 👉 @Mike22332233 ...
3 · Reply
Mike22332233
Mike22332233 May. 16 at 9:29 PM
$SLS PART 2 of 2 .. Even with the BAT arm at 14.7 mOS which is almost twice as long as should be expected … EFFECTIVELY, those getting GPS that had an immune response (80% of them) ARE NOT PASSING AWAY!!! ... GAME CHANGING FOR CANCER !!! When the trial ends at the 80th event, I believe you would have ALL 63 in the BAT Control arm passed away, AND ONLY 17 OF THE 63 GPS PATIENTS PASSED AWAY … 46 of the 63 will be alive and living into their 4th yr and some into their 5th year…. This has EFFECTIVELY STOPPED CANCER FROM KILLING THEM IN THIS TYPE OF CANCER !! ... There are an additional 20 or so Cancers with the WT1 within them … as I said before, likely $ABBV or $MEK or $PFE doing a BUY OUT WITHIN 3 months of the readout, and my MAXIMUM PRICE OF $150 to $175 (a $30 to $35 Billion valuation) for the BO may very well be much too low if the HR is GAME-CHANGING at 0.27-0.35 ... if so, expect a bidding war and final BO at $222 !!! ... If you agree then LIKE this and FOLLOW me 👉 @Mike22332233
3 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 16 at 7:13 PM
$SLS it is inevitable - the 80th Event PR is coming, Phase 3 Registrational Results and FDA Green light worth $40B to big Pharma - are Coming. ANY - DAY - NOW GPS P3 Results - truly worth $40B + the Instant the REGAL Results are announced - GPS MOS 30-36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the $10B MCap Range / $50 Per Share - AND CLIMBING And to Bottom LINE 009 / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value. Gleevc - Imatinib, Imbrutinib - Imbruvica, Upadactinib - Rinvoq Upadactinib <- say that 3 x fast $PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor Novartis' Kisqali -Ribociclib CDKinase Inhibitor $LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor $SLS Tambiciclib CDKInase Inhibitor reddit.com/r/sellasLifescience ... for anyone interested in DD/ i been here -invested a long time/ if you have an interest in $
0 · Reply
morgangj
morgangj May. 16 at 4:00 PM
$PFE
0 · Reply
morgangj
morgangj May. 16 at 3:23 PM
$PFE
0 · Reply
morgangj
morgangj May. 16 at 3:18 PM
$PFE
0 · Reply
IdioSyncro
IdioSyncro May. 16 at 2:05 AM
$PFE
0 · Reply
pasuny
pasuny May. 16 at 12:44 AM
$PFE it's been 5 Pho King years...
1 · Reply
pasuny
pasuny May. 16 at 12:41 AM
$PFE 씨발 젖같네 도대체 왜 이러지? 씨발 좆도 5년동안 빌빌 거리네... 좆도 씨발 물려서 팔지도 못 하고... 진짜 개좆같네... 씨발 경영진...
0 · Reply
morgangj
morgangj May. 15 at 11:34 PM
$PFE
0 · Reply
grampslol
grampslol May. 15 at 11:13 PM
Poor $MNKD pumpy clan... shh... deluding himself as he tries to deceive others about afrezza dpi inhaled insulin approved in 2014...the only insulin with the FDA black box warning label... scripts for week ending 5/8/26 New 338 refills 438...#afizzle $PFE $AMGN $MRK #coughcough
1 · Reply
clan
clan May. 15 at 10:36 PM
$MNKD 🍻 $PFE 🤪 $MRK 🍾 $AMGN Who knew?!? Inhalable mealtime insulin!! For the good of all Mannkind!
0 · Reply
Skyhigh_69
Skyhigh_69 May. 15 at 9:36 PM
$PFE Reckon 24's the bottom? Maybe I'll enter
2 · Reply
Jalard
Jalard May. 15 at 9:27 PM
$PFE looking for this to get to $27
2 · Reply
AtlantaOracle
AtlantaOracle May. 15 at 9:08 PM
$MRNA $SPY $PFE if this is reel?! 😆 $TSLA $QQQ https://www.instagram.com/reel/DYXNZvHP0_p/?igsh=MXYxdmZhcm53b3FxYg==
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 15 at 9:01 PM
$SLS GPS P3 Results are worth - truly worth $40B + the Instant the REGAL Results are announced - GPS MOS 30 - 36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the $10B MCap Range / $50 Per Share Range - AND CLIMBING And to Bottom LINE 009 / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value. Gleevc - Imatinib Imbrutinib - Imbruvica Upadactinib - Rinvoq Upadactinib <- say that 3 x fast $PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor $NVS Novartis' Kisqali -Ribociclib CDKinase Inhibitor $LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor $SLS ufTambiciclib CDKInase Inhibitor. https://www.reddit.com/r/sellasLifescience/search/?q=aml-mr&cId=057d1aab-2b7d-4bf0-a2d4-c3227af101f8&iId=8d5110f2-0189-40ea-bc04-b363b5cad724 for anyone interested in DD/ i been here invested a long time/ if you have an interest in understanding why 009 / Gps these SLS Shares are trading / short / warrant manipulative share price management -reality is GPS P3 Results are now Imminent and - truly worth $40B + the moment the REGAL Trial Results are announced.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 15 at 8:50 PM
$SLS Hope. A beautiful Message of Hope today from our CEO. God Speed and Strength to the entire SLS Community, patients foremost - god bless the 128 Enrolled and 49 who remain, and the Dr's, Clinicians and staff, Steering Committee and IDMC and the entire SLS Corporate Team - and the Inch thick, them too. City of Hope Recruiting AML-MR Patients 35% of AML, at 4 New Locations in Atlanta, Chicago, Phoenix and Los Angeles - Fund managers, discussing SLS / GPS / SLS009 with Angelos will discover these shares stack up to a mountain of Value. 40x + Potential ROI. This AML Platform is for Sale $LLY $PFE $ABBV Gps a Safe AML Remission Maintenance Immunotherapy - Extends OS by Years - and 009 the first On Target CDk9 Inhibitor Fund Managers will continue Feasting on SLS Shares next week after the Conferences.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 15 at 8:44 PM
$PFE tech sold off hard today and we still underperformed tech lmfao
3 · Reply
Itsokman
Itsokman May. 15 at 8:15 PM
$PFE Tough day 🤠
0 · Reply
pasuny
pasuny May. 15 at 8:13 PM
$PFE 개씨발 개잡주
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ May. 15 at 7:58 PM
$PFE when we close red again.
0 · Reply